These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 4439853)

  • 21. [Use of immunofluorescence for the detection of antibodies and visualization of the antigen in lymphocytic choriomeningitis].
    Hronovský V; Benda R; Procházka O
    Cesk Epidemiol Mikrobiol Imunol; 1969 Mar; 18(2):90-7. PubMed ID: 4238404
    [No Abstract]   [Full Text] [Related]  

  • 22. Infection of Syrian hamsters with lymphocytic choriomeningitis virus: comparison of detection methods.
    Thacker WL; Lewis VJ; Shaddock JH; Winkler WG
    Am J Vet Res; 1982 Aug; 43(8):1500-2. PubMed ID: 7049024
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Virus-specific IgD in acute viral infection of mice.
    Moskophidis D; Moskophidis M; Löhler J
    J Immunol; 1997 Feb; 158(3):1254-61. PubMed ID: 9013967
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lymphocytic choriomeningitis virus: pathogenesis of acute central nervous system disease.
    Cole GA; Gilden DH; Monjan AA; Nathanson N
    Fed Proc; 1971; 30(6):1831-41. PubMed ID: 4942053
    [No Abstract]   [Full Text] [Related]  

  • 25. Pathogenesis of cerebellar hypoplasia produced by lymphocytic choriomeningitis virus infection of neonatal rats. 1. Evolution of disease following infection at 4 days of age.
    Monjan AA; Cole GA; Gilden DH; Nathanson N
    J Neuropathol Exp Neurol; 1973 Jan; 32(1):110-24. PubMed ID: 4568304
    [No Abstract]   [Full Text] [Related]  

  • 26. B cell responses and immune memory.
    Slifka MK; Ahmed R
    Dev Biol Stand; 1998; 95():105-15. PubMed ID: 9855420
    [No Abstract]   [Full Text] [Related]  

  • 27. A rapid fluorescent focus-inhibition test for determining the neutralizing-antibody response to lymphocytic choriomeningitis virus.
    Thacker WL; Lewis VJ; Haller GJ; Baer GM
    Can J Microbiol; 1977 May; 23(5):522-6. PubMed ID: 326357
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interactions between viruses and lymphocytes. I. In vivo replication of lymphocytic choriomeningitis virus in mononuclear cells during both chronic and acute viral infections.
    Doyle MV; Oldstone MB
    J Immunol; 1978 Oct; 121(4):1262-9. PubMed ID: 308960
    [No Abstract]   [Full Text] [Related]  

  • 29. Studies on immunity to lymphocytic choriomeningitis virus.
    Zinkernagel RM; Leist T; Hengartner H; Pestalozzi B; Stitz L
    Med Microbiol Immunol; 1986; 175(2-3):209-11. PubMed ID: 3523184
    [No Abstract]   [Full Text] [Related]  

  • 30. Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus. I. Generation and recognition of virus strains and H-2b mutants.
    Byrne JA; Ahmed R; Oldstone MB
    J Immunol; 1984 Jul; 133(1):433-9. PubMed ID: 6202788
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunopathologic alterations of lymphatic tissues of mice infected with lymphocytic choriomeningitis virus. II. Pathogenetic mechanism.
    Lehmann-Grube F; Löhler J
    Lab Invest; 1981 Mar; 44(3):205-13. PubMed ID: 7464046
    [No Abstract]   [Full Text] [Related]  

  • 32. Virus-induced immune complex disease: specific anti-viral antibody and C1q binding material in the circulation during persistent lymphocytic choriomeningitis virus infection.
    Oldstone MB; Buchmeier MJ; Doyle MV; Tishon A
    J Immunol; 1980 Feb; 124(2):831-8. PubMed ID: 6444319
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunopathogenesis of LCM virus-induced uveitis: the role of T lymphocytes.
    Ticho U; Silverstein AM; Cole GA
    Invest Ophthalmol; 1974 Mar; 13(3):229-31. PubMed ID: 4591832
    [No Abstract]   [Full Text] [Related]  

  • 34. Nonneutralizing antibodies binding to the surface glycoprotein of lymphocytic choriomeningitis virus reduce early virus spread.
    Hangartner L; Zellweger RM; Giobbi M; Weber J; Eschli B; McCoy KD; Harris N; Recher M; Zinkernagel RM; Hengartner H
    J Exp Med; 2006 Aug; 203(8):2033-42. PubMed ID: 16880253
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mapping arenavirus genes causing virulence.
    Riviere Y
    Curr Top Microbiol Immunol; 1987; 133():59-65. PubMed ID: 2435461
    [No Abstract]   [Full Text] [Related]  

  • 36. Complement-fixing antigen from BHK-21 cell cultures infected with lymphocytic choriomeningitis virus.
    Brown WJ; Kirk BE
    Appl Microbiol; 1969 Sep; 18(3):496-9. PubMed ID: 4984767
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Capacity of sensitized thymus-derived lymphocytes to induce fatal lymphocytic choriomeningitis is restricted by the H-2 gene complex.
    Doherty PC; Zinernagel RM
    J Immunol; 1975 Jan; 114(1 Pt 1):30-3. PubMed ID: 1078677
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A powerful and simply-prepared complement fixing antigen for lymphocytic choriomeningitis virus].
    Chastel C; Le Noc P
    Ann Inst Pasteur (Paris); 1968 May; 114(5):698-704. PubMed ID: 4999689
    [No Abstract]   [Full Text] [Related]  

  • 39. Beneficial effect of cyclosporin A on the lymphocytic choriomeningitis virus infection in mice.
    Saron MF; Shidani B; Guillon JC; Truffa-Bachi P
    Eur J Immunol; 1984 Nov; 14(11):1064-6. PubMed ID: 6499908
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The immune response of the mouse to lymphocytic choriomeningitis virus. IV. Enumeration of antibody-producing cells in spleens during acute and persistent infection.
    Moskophidis D; Lehmann-Grube F
    J Immunol; 1984 Dec; 133(6):3366-70. PubMed ID: 6092472
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.